Exopolysaccharides from Cyanobacterium aponinum from the Blue Lagoon in Iceland increase IL-10 secretion by human dendritic cells and their ability to reduce the IL-17+RORγt+/IL-10+FoxP3+ ratio in CD4+ T cells

Immunol Lett. 2015 Feb;163(2):157-62. doi: 10.1016/j.imlet.2014.11.008. Epub 2014 Dec 9.

Abstract

Regular bathing in the Blue Lagoon in Iceland has beneficial effects on psoriasis. Cyanobacterium aponinum is a dominating member of the Blue Lagoon's microbial ecosystem. The aim of the study was to determine whether exopolysaccharides (EPSs) secreted by C. aponinum (EPS-Ca) had immunomodulatory effects in vitro. Human monocyte-derived dendritic cells (DCs) were matured in the absence or presence of EPS-Ca and the effects were determined by measuring the secretion of cytokines by ELISA and the expression of surface molecules by flow cytometry. DCs matured with EPS-Ca at 100 μg/ml secreted higher levels of IL-10 than untreated DCs. Subsequently, DCs matured in the presence or absence of EPS-Ca were co-cultured with allogeneic CD4(+) T cells and their effects on T cell activation analysed by measuring expression of intracellular and surface molecules and cytokine secretion. Supernatant from allogeneic T cells co-cultured with EPS-Ca-exposed DCs had raised levels of IL-10 compared with control. A reduced frequency of IL-17(+)RORγt(+) T cells was observed when co-cultured with EPS-Ca-exposed DCs and a tendency towards increased frequency of FoxP3(+)IL-10(+) T cells, resulting in a lower IL-17(+)RORγt(+)/FoxP3(+)IL-10(+) ratio. The study shows that EPSs secreted by C. aponinum stimulate DCs to produce vast amounts of the immunosuppressive cytokine IL-10. These DCs induce differentiation of allogeneic CD4(+) T cells with an increased Treg but decreased Th17 phenotype. These data suggest that EPSs from C. aponinum may play a role in the beneficial clinical effect on psoriasis following bathing in the Blue Lagoon.

Keywords: Allogeneic T cells; Blue Lagoon; Cyanobacterium aponinum; Dendritic cells; Exopolysaccharides; Immunomodulating effects.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD4-Positive T-Lymphocytes / drug effects
  • CD4-Positive T-Lymphocytes / immunology*
  • CD4-Positive T-Lymphocytes / metabolism
  • Cell Differentiation / immunology
  • Cells, Cultured
  • Coculture Techniques
  • Culture Media, Conditioned / metabolism
  • Culture Media, Conditioned / pharmacology
  • Cyanobacteria / chemistry
  • Dendritic Cells / drug effects
  • Dendritic Cells / immunology*
  • Dendritic Cells / metabolism
  • Enzyme-Linked Immunosorbent Assay
  • Flow Cytometry
  • Forkhead Transcription Factors / immunology*
  • Forkhead Transcription Factors / metabolism
  • Humans
  • Iceland
  • Immunologic Factors / pharmacology
  • Interleukin-10 / immunology*
  • Interleukin-10 / metabolism
  • Interleukin-17 / immunology*
  • Interleukin-17 / metabolism
  • Lymphocyte Activation / immunology
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / immunology*
  • Nuclear Receptor Subfamily 1, Group F, Member 3 / metabolism
  • Polysaccharides, Bacterial / immunology*
  • Polysaccharides, Bacterial / pharmacology
  • Water Microbiology

Substances

  • Culture Media, Conditioned
  • FOXP3 protein, human
  • Forkhead Transcription Factors
  • Immunologic Factors
  • Interleukin-17
  • Nuclear Receptor Subfamily 1, Group F, Member 3
  • Polysaccharides, Bacterial
  • Interleukin-10